Scandinavian ChemoTech: Insider Debt Conversion and Increased Flexibility - Redeye
Bildkälla: Stockfoto

Scandinavian ChemoTech: Insider Debt Conversion and Increased Flexibility - Redeye

A directed issue of SEK2.55m, settled via debt offset by insiders, provides some balance sheet relief. The more interesting story is a proposed move toward a more decentralised structure enabling subsidiary-level financing, potentially reducing parent-level dilution going forward. Changes require both AGM and Nasdaq approval.

A directed issue of SEK2.55m, settled via debt offset by insiders, provides some balance sheet relief. The more interesting story is a proposed move toward a more decentralised structure enabling subsidiary-level financing, potentially reducing parent-level dilution going forward. Changes require both AGM and Nasdaq approval.
Börsvärldens nyhetsbrev